» Articles » PMID: 33389421

COVID-19 Vaccination Hesitancy in the United States: A Rapid National Assessment

Overview
Publisher Springer
Specialty Public Health
Date 2021 Jan 3
PMID 33389421
Citations 594
Authors
Affiliations
Soon will be listed here.
Abstract

Given the results from early trials, COVID-19 vaccines will be available by 2021. However, little is known about what Americans think of getting immunized with a COVID-19 vaccine. Thus, the purpose of this study was to conduct a comprehensive and systematic national assessment of COVID-19 vaccine hesitancy in a community-based sample of the American adult population. A multi-item valid and reliable questionnaire was deployed online via mTurk and social media sites to recruit U.S. adults from the general population. A total of 1878 individuals participated in the study where the majority were: females (52%), Whites (74%), non-Hispanic (81%), married (56%), employed full time (68%), and with a bachelor's degree or higher (77%). The likelihood of getting a COVID-19 immunization in the study population was: very likely (52%), somewhat likely (27%), not likely (15%), definitely not (7%), with individuals who had lower education, income, or perceived threat of getting infected being more likely to report that they were not likely/definitely not going to get COVID-19 vaccine (i.e., vaccine hesitancy). In unadjusted group comparisons, compared to their counterparts, vaccine hesitancy was higher among African-Americans (34%), Hispanics (29%), those who had children at home (25%), rural dwellers (29%), people in the northeastern U.S. (25%), and those who identified as Republicans (29%). In multiple regression analyses, vaccine hesitancy was predicted significantly by sex, education, employment, income, having children at home, political affiliation, and the perceived threat of getting infected with COVID-19 in the next 1 year. Given the high prevalence of COVID-19 vaccine hesitancy, evidence-based communication, mass media strategies, and policy measures will have to be implemented across the U.S. to convert vaccines into vaccinations and mass immunization with special attention to the groups identified in this study.

Citing Articles

Hesitancy towards COVID-19 booster vaccine among healthcare workers in Bangladesh.

Shoshi H, Basher A, Pyash A, Hossain M, Chowdhury F, Hassan M BMC Health Serv Res. 2025; 25(1):346.

PMID: 40050921 PMC: 11884019. DOI: 10.1186/s12913-025-12482-6.


Suspicion and other feelings about COVID-19 vaccines and mask-wearing among individuals recovering from substance addiction.

Hassett-Walker C Public Health Pract (Oxf). 2025; 9:100599.

PMID: 40040672 PMC: 11879660. DOI: 10.1016/j.puhip.2025.100599.


Racial Influences, Social Media Usage, and Vaccine Hesitancy: A National Survey Across Vaccine Topics.

Li R, Zhou Y, Shen L, Li W J Racial Ethn Health Disparities. 2025; .

PMID: 40038235 DOI: 10.1007/s40615-025-02332-w.


COVID-19-related stress, anxiety and vaccine hesitancy among healthcare workers in a tertiary hospital in South-Western Nigeria.

Ojo T, Adetunji T, Eneh S, Akanji B, Fajobi O, Elugbaju O Sci Rep. 2025; 15(1):4112.

PMID: 39900575 PMC: 11791170. DOI: 10.1038/s41598-024-84195-5.


Critical thinking about health and treatments in the United States: a cross-sectional assessment of parents and undergraduate college students.

Ringle V, Dahlgren A, Rosenbaum S, Jensen-Doss A BMC Public Health. 2025; 25(1):336.

PMID: 39871266 PMC: 11771010. DOI: 10.1186/s12889-025-21291-9.


References
1.
Fisher K, Bloomstone S, Walder J, Crawford S, Fouayzi H, Mazor K . Attitudes Toward a Potential SARS-CoV-2 Vaccine : A Survey of U.S. Adults. Ann Intern Med. 2020; 173(12):964-973. PMC: 7505019. DOI: 10.7326/M20-3569. View

2.
Cohen J . Vaccine wagers on coronavirus surface protein pay off. Science. 2020; 370(6519):894-895. DOI: 10.1126/science.370.6519.894. View

3.
Webb F, Khubchandani J, Striley C, Cottler L . Black-White Differences in Willingness to Participate and Perceptions About Health Research: Results from the Population-Based HealthStreet Study. J Immigr Minor Health. 2018; 21(2):299-305. PMC: 6701178. DOI: 10.1007/s10903-018-0729-2. View

4.
Malik A, McFadden S, Elharake J, Omer S . Determinants of COVID-19 vaccine acceptance in the US. EClinicalMedicine. 2020; 26:100495. PMC: 7423333. DOI: 10.1016/j.eclinm.2020.100495. View

5.
Lazarus J, Ratzan S, Palayew A, Gostin L, Larson H, Rabin K . A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. 2020; 27(2):225-228. PMC: 7573523. DOI: 10.1038/s41591-020-1124-9. View